Literature DB >> 21883143

Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Dimitris K Grammatopoulos1.   

Abstract

During evolution, mammals have developed remarkably similar molecular mechanisms to respond to external challenges and maintain survival. Critical regulators of these mechanisms are the family of 'stress'-peptides that consists of the corticotropin-releasing hormone (CRH) and urocortins (Ucns). These neuropeptides 'fine-tune' integration of an intricate series of physiological responses involving the autonomic, endocrine, immune, cardiovascular and reproductive systems, which induce a spectrum of behavioural and homeostatic changes. CRH and Ucns exert their actions by activating two types of CRH receptors (CRH-R), CRH-R1 and CRH-R2, which belong to the class-B1 family of GPCRs. The CRH-Rs exhibit signalling promiscuity facilitated by their ability to couple to multiple G-proteins and regulate diverse intracellular networks that involve intracellular effectors such as cAMP and an array of PKs in an agonist and tissue-specific manner, a property that allows them to exert unique roles in the integration of homeostatic mechanisms. We only now begin to unravel the plethora of CRH-R biological actions and the transcriptional and post-translational mechanisms such as alternative mRNA splicing or phosphorylation-mediated desensitization developed to tightly control CRH-Rs biological activity and regulate their physiological actions. This review summarizes the current understanding of CRH-R signalling complexity and regulatory mechanisms that underpin cellular responses to CRH and Ucns.
© 2011 The Author. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21883143      PMCID: PMC3415640          DOI: 10.1111/j.1476-5381.2011.01631.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  98 in total

Review 1.  CRF and CRF receptors: role in stress responsivity and other behaviors.

Authors:  Tracy L Bale; Wylie W Vale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

2.  Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus.

Authors:  S Vincent Wu; Pu-qing Yuan; Lixin Wang; Yen L Peng; Chih-Yen Chen; Yvette Taché
Journal:  Endocrinology       Date:  2007-01-11       Impact factor: 4.736

3.  Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.

Authors:  H Berger; N Heinrich; D Wietfeld; M Bienert; M Beyermann
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

4.  Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation.

Authors:  Anu Punn; Michael A Levine; Dimitris K Grammatopoulos
Journal:  Mol Endocrinol       Date:  2006-09-07

5.  A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissue.

Authors:  Jennifer A Ralph; Davide Zocco; Barry Bresnihan; Oliver Fitzgerald; Alice N McEvoy; Evelyn P Murphy
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

6.  Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.

Authors:  Grazia Graziani; Lucio Tentori; Alessia Muzi; Matteo Vergati; Giuseppe Tringali; Giacomo Pozzoli; Pierluigi Navarra
Journal:  Mol Cell Endocrinol       Date:  2006-11-09       Impact factor: 4.102

7.  Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.

Authors:  Bhawanjit K Brar; Anne K Jonassen; Elena M Egorina; Alon Chen; Alejandra Negro; Marilyn H Perrin; Ole D Mjøs; David S Latchman; Kuo-Fen Lee; Wylie Vale
Journal:  Endocrinology       Date:  2003-09-11       Impact factor: 4.736

8.  Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity.

Authors:  Nikolleta Papadopoulou; Jing Chen; Harpal S Randeva; Michael A Levine; Edward W Hillhouse; Dimitris K Grammatopoulos
Journal:  Mol Endocrinol       Date:  2003-12-04

9.  Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.

Authors:  Bhawanjit K Brar; Alon Chen; Marilyn H Perrin; Wylie Vale
Journal:  Endocrinology       Date:  2003-12-11       Impact factor: 4.736

10.  NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene.

Authors:  Katia P Karalis; Maria Venihaki; Jie Zhao; Lilian E van Vlerken; Christina Chandras
Journal:  J Biol Chem       Date:  2004-01-06       Impact factor: 5.157

View more
  38 in total

1.  Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives.

Authors:  David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Perturbations of Neuron-Restrictive Silencing Factor Modulate Corticotropin-Releasing Hormone Gene Expression in the Human Cell Line BeWo.

Authors:  Vasileios Kreouzis; Guo-Lin Chen; Gregory M Miller
Journal:  Mol Neuropsychiatry       Date:  2018-09-19

3.  Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Sandra Braun; Judith Hernandez-Aranda; Christine C Hudson; Eric Gutknecht; Frank M Dautzenberg; Robert H Oakley
Journal:  Regul Pept       Date:  2013-06-29

Review 4.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway.

Authors:  Sang Hoon Rhee; Elise L Ma; Yunna Lee; Yvette Taché; Charalabos Pothoulakis; Eunok Im
Journal:  J Biol Chem       Date:  2015-09-08       Impact factor: 5.157

Review 7.  Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.

Authors:  Y Taché
Journal:  Neurogastroenterol Motil       Date:  2015-01       Impact factor: 3.598

8.  Estradiol-Dependent Stimulation and Suppression of Gonadotropin-Releasing Hormone Neuron Firing Activity by Corticotropin-Releasing Hormone in Female Mice.

Authors:  Chayarndorn Phumsatitpong; Suzanne M Moenter
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

9.  Differential activation of neuronal cell types in the basolateral amygdala by corticotropin releasing factor.

Authors:  Amanda B Rostkowski; Randy J Leitermann; Janice H Urban
Journal:  Neuropeptides       Date:  2013-05-18       Impact factor: 3.286

Review 10.  Key role of CRF in the skin stress response system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Desmond J Tobin; Theoharis C Theoharides; Jean Rivier
Journal:  Endocr Rev       Date:  2013-08-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.